Johnson & Johnson officials said its coronavirus vaccine is effective against the delta variant of the virus that health experts worry could cause another surge nationwide among the unvaccinated.
The company said Thursday its one-dose shot defends against the variant, citing lab tests of vaccine recipients’ blood, USA Today reported.
Company officials speculate the immune response may last more than eight months.
The Food and Drug Administration temporarily paused the distribution of the one-dose Johnson & Johnson vaccine in early April after concerns of a connection to a rare blood clotting condition, but rescinded the order less than two weeks later.
The delta variant of the coronavirus — a more contagious strain fueling recent outbreaks worldwide — has now been found in all 50 states and the District, according to a recent report.
The Centers for Disease Control and Prevention (CDC) estimates that 26.1% of all cases are now caused by the variant.
Dr. Rochelle Walensky, CDC director, said unvaccinated Americans need to get a coronavirus shot to stop the spread of the delta variant.
“Any suffering or death from COVID-19 is tragic,” Walensky said, USA Today reported. “With vaccines available across the country, the suffering and loss we are now seeing is nearly entirely avoidable.”

WI Guest Author

This correspondent is a guest contributor to The Washington Informer.

Leave a comment

Your email address will not be published.